Stratum Biosciences Inc.

MADISON, MS · Founded 2023 · CIK 0001999196 · Biotech · Private

AI-driven biomarker discovery platform and skin-penetrating molecular delivery systems for therapeutic development

stratumbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$100K
2 Form D · Dec 2025
10 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$100,000
Private capital raisedForm D · SEC$550,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1612GATC HEALTH CORP—$981K
1613DIVERSE BIOTECH, INC.—$669K
1614XORTX Therapeutics Inc.—$505K
1615Stratum Biosciences Inc.—$100K
1616Generate Biomedicines——
1617Provizigen LLC——
1618ALZHEON, INC.—$134M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Buu DuongDirector · Executive Officer
  • Ross Pearlman, MDDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.